ArticleJCI insight2018

CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients.

Diane Goltz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.